Magnesium Supplementation and Blood Pressure Reduction
Not Applicable
Active, not recruiting
- Conditions
- Blood Pressure
- Interventions
- Dietary Supplement: magnesium glycinate supplementDietary Supplement: placebo
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 59
- Registration Number
- NCT03688503
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Feasibility of a Yoga- and Mindfulness-Based Intervention for Resident Physicians
Not Applicable
Completed
- Conditions
- AnxietyBurnout, ProfessionalDepressionStress
- Interventions
- Behavioral: RISE yoga-based program
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT03687450
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Mineralocorticoid Receptor (MR) Antagonist (Eplerenone) vs Amlodipine and STRIATIN
Phase 4
Completed
- Conditions
- HypertensionGenetics Hypertension
- Interventions
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03683069
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
Not Applicable
Completed
- Conditions
- HypertensionChronic Kidney Diseases
- Interventions
- Other: ControlOther: Intervention
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 2026
- Registration Number
- NCT03679247
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2022-10-05
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT03675022
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Phase 2
Completed
- Conditions
- Myalgic Encephalomyelitis/Chronic Fatigue SyndromeChronic Fatigue SyndromeMyalgic EncephalomyelitisExercise IntoleranceDysautonomiaLow Ventricular Filling Pressures (Preload Failure)Postural Orthostatic Tachycardia SyndromeFibromyalgiaOrthostatic Hypotension
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT03674541
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Virtual Visits for Results Disclosure
Not Applicable
Withdrawn
- Conditions
- Genetic Disease
- Interventions
- Other: Virtual Visit
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT03658382
Effects of Biktarvy on CFR in Stable HIV Patients
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT03656783
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
🇺🇸Boston Medical Center, Boston, Massachusetts, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
Not Applicable
Completed
- Conditions
- Hematologic MalignancyBlood CancerHematopoietic/Lymphoid Cancer
- Interventions
- Behavioral: Positive Psychology Intervention
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT03654404
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Use of Transcranial Magnetic Stimulation to Reduce Craving for Individuals With Opioid Use Disorder Taking Buprenorphine
Not Applicable
Withdrawn
- Conditions
- Opioid-use Disorder
- Interventions
- Device: Transcranial Magnetic Stimulation
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT03653169
- Locations
- 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath